HLA-A*9, a probable secondary susceptibility marker to ankylosing spondylitis in Basque patients

Tissue Antigens. 1999 Feb;53(2):161-6. doi: 10.1034/j.1399-0039.1999.530206.x.

Abstract

HLA-B27 is strongly associated to ankylosing spondylitis (AS). The objective of our study was to analyze HLA-B27 association, B27 subtype distribution and frequency of other HLA class I and DR antigens in a group of Basque AS patients. HLA class I antigens were typed serologically and HLA-B27 and A9 subtypes were determined by DNA typing in samples from 46 patients with AS, 54 B27-positive spondyloarthropathies, 82 healthy subjects and 20 B27-positive controls. A class I HLA 9.2 kb PvuII restriction fragment length polymorphism (RFLP), previously associated with AS, was analyzed in a representative group of patients and controls. We found that HLA-B*2705 conferred a relative risk of 126 for AS in this group. HLA-A9 (A*2402) allele was significantly increased in AS patients compared with healthy controls and B27-positive control group (Pcorr<0.0001) and also increased in patients affected with peripheral arthritis. No association between class I HLA 9.2 Kb RFLP and AS was found. These results suggest that HLA-A*9 allele itself or another linked gene could act as a secondary and independent susceptibility allele to AS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Biomarkers
  • Deoxyribonucleases, Type II Site-Specific
  • Disease Susceptibility
  • Female
  • HLA-A Antigens / genetics*
  • Histocompatibility Antigens Class I / genetics
  • Histocompatibility Antigens Class II / genetics
  • Humans
  • Male
  • Middle Aged
  • Polymorphism, Restriction Fragment Length
  • Spain
  • Spondylitis, Ankylosing / genetics*

Substances

  • Biomarkers
  • HLA-A Antigens
  • HLA-A9 antigen
  • Histocompatibility Antigens Class I
  • Histocompatibility Antigens Class II
  • CAGCTG-specific type II deoxyribonucleases
  • Deoxyribonucleases, Type II Site-Specific